Julhash U. Kazi

3.0k total citations · 1 hit paper
85 papers, 2.1k citations indexed

About

Julhash U. Kazi is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Julhash U. Kazi has authored 85 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 28 papers in Hematology and 23 papers in Oncology. Recurrent topics in Julhash U. Kazi's work include Acute Myeloid Leukemia Research (23 papers), PI3K/AKT/mTOR signaling in cancer (14 papers) and Chronic Myeloid Leukemia Treatments (14 papers). Julhash U. Kazi is often cited by papers focused on Acute Myeloid Leukemia Research (23 papers), PI3K/AKT/mTOR signaling in cancer (14 papers) and Chronic Myeloid Leukemia Treatments (14 papers). Julhash U. Kazi collaborates with scholars based in Sweden, United States and Bangladesh. Julhash U. Kazi's co-authors include Lars Rönnstrand, Jianmin Sun, Kinjal Shah, Nuzhat N. Kabir, Amr Al‐Haidari, Jae‐Won Soh, Amilcar Flores‐Morales, S. M. Riazul Islam, Shruti Agarwal and Hui Zhao and has published in prestigious journals such as Journal of Biological Chemistry, Physiological Reviews and Blood.

In The Last Decade

Julhash U. Kazi

81 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

T cell receptor (TCR) signaling in health and disease

2021 332 citations Kinjal Shah, Jianmin Sun et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julhash U. Kazi Sweden	26	1.1k	540	514	443	295	85	2.1k
Andrew Pierce United Kingdom	23	1.3k 1.1×	575 1.1×	423 0.8×	254 0.6×	287 1.0×	69	2.2k
Alison M. Michie United Kingdom	27	1.2k 1.1×	463 0.9×	486 0.9×	1.0k 2.3×	347 1.2×	67	2.5k
Jasper de Boer United Kingdom	22	1.2k 1.0×	477 0.9×	342 0.7×	787 1.8×	143 0.5×	43	2.2k
Josée Hébert Canada	33	2.2k 1.9×	947 1.8×	550 1.1×	443 1.0×	257 0.9×	93	3.1k
Stacey J. Baker United States	18	1.3k 1.2×	343 0.6×	615 1.2×	547 1.2×	259 0.9×	34	2.3k
Meike Vogler Germany	26	2.1k 1.9×	290 0.5×	769 1.5×	563 1.3×	396 1.3×	59	2.9k
Rebecca J. Chan United States	32	2.2k 1.9×	580 1.1×	531 1.0×	917 2.1×	349 1.2×	90	3.3k
N. Shaun B. Thomas United Kingdom	30	1.9k 1.7×	449 0.8×	735 1.4×	778 1.8×	326 1.1×	56	3.1k
Dorina Gui United States	23	862 0.8×	236 0.4×	345 0.7×	211 0.5×	191 0.6×	52	1.7k

Countries citing papers authored by Julhash U. Kazi

Since Specialization

Citations

This map shows the geographic impact of Julhash U. Kazi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julhash U. Kazi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julhash U. Kazi more than expected).

Fields of papers citing papers by Julhash U. Kazi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julhash U. Kazi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julhash U. Kazi. The network helps show where Julhash U. Kazi may publish in the future.

Co-authorship network of co-authors of Julhash U. Kazi

This figure shows the co-authorship network connecting the top 25 collaborators of Julhash U. Kazi. A scholar is included among the top collaborators of Julhash U. Kazi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julhash U. Kazi. Julhash U. Kazi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rinaldo-Matthis, Agnes, et al.. (2024). Discovery of a small molecule that inhibits Bcl-3-mediated cyclin D1 expression in melanoma cells. BMC Cancer. 24(1). 103–103. 5 indexed citations

Bocci, Matteo, et al.. (2024). Spatial Multiomics Reveals Intratumoral Immune Heterogeneity with Distinct Cytokine Networks in Lung Cancer Brain Metastases. Cancer Research Communications. 4(11). 2888–2902. 1 indexed citations

Tran, Thi Thu Phuong, Mohamed Jèmaà, Wondossen Sime, et al.. (2024). Enhancing cell death in B-cell malignancies through targeted inhibition of Bcl-3. Cell Death and Disease. 15(9). 690–690. 3 indexed citations

Hammarlund, Emma U., et al.. (2024). XeroGraph: enhancing data integrity in the presence of missing values with statistical and predictive analysis. Bioinformatics Advances. 5(1). vbaf035–vbaf035. 1 indexed citations

Kazi, Julhash U., et al.. (2024). Alterations of the chemical profile of cholesterol in cancer tissue as traced with ToF-SIMS. The Analyst. 149(21). 5344–5352. 5 indexed citations

Shah, Kinjal, et al.. (2023). Venetoclax-Resistant T-ALL Cells Display Distinct Cancer Stem Cell Signatures and Enrichment of Cytokine Signaling. International Journal of Molecular Sciences. 24(5). 5004–5004. 6 indexed citations

Kazi, Julhash U., et al.. (2018). SRC-like adaptor protein 2 (SLAP2) is a negative regulator of KIT-D816V-mediated oncogenic transformation. Scientific Reports. 8(1). 6405–6405. 3 indexed citations

Kazi, Julhash U. & Lars Rönnstrand. (2018). The role of SRC family kinases in FLT3 signaling. The International Journal of Biochemistry & Cell Biology. 107. 32–37. 20 indexed citations

Shah, Kinjal, et al.. (2018). Acute leukemia cells resistant to PI3K/mTOR inhibition display upregulation of P2RY14 expression. Clinical Epigenetics. 10(1). 83–83. 22 indexed citations

10.

Shah, Kinjal, et al.. (2017). T-cell Acute Lymphoblastic Leukemia Cells Display Activation of Different Survival Pathways. Journal of Cancer. 8(19). 4124–4124. 11 indexed citations

11.

Kazi, Julhash U., et al.. (2017). The dual specificity PI3K/mTOR inhibitor PKI-587 displays efficacy against T-cell acute lymphoblastic leukemia (T-ALL). Cancer Letters. 392. 9–16. 43 indexed citations

12.

Persson, C., Julhash U. Kazi, Lars Rönnstrand, et al.. (2016). HIF2α contributes to antiestrogen resistance via positive bilateral crosstalk with EGFR in breast cancer cells. Oncotarget. 7(10). 11238–11250. 19 indexed citations

13.

Ke, Hengning, Julhash U. Kazi, Hui Zhao, & Jianmin Sun. (2016). Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis. Cell & Bioscience. 6(1). 55–55. 37 indexed citations

14.

Kazi, Julhash U., Nuzhat N. Kabir, & Lars Rönnstrand. (2015). Role of SRC-like adaptor protein (SLAP) in immune and malignant cell signaling. Cellular and Molecular Life Sciences. 72(13). 2535–2544. 15 indexed citations

15.

Kazi, Julhash U., Nuzhat N. Kabir, & Lars Rönnstrand. (2015). Brain-Expressed X-linked (BEX) proteins in human cancers. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1856(2). 226–233. 29 indexed citations

16.

Kabir, Nuzhat N., et al.. (2015). The role of HOXB2 and HOXB3 in acute myeloid leukemia. Biochemical and Biophysical Research Communications. 467(4). 742–747. 29 indexed citations

17.

Zhang, Jing, Olesya Vakhrusheva, Srinivasa Rao Bandi, et al.. (2015). The Phosphatases STS1 and STS2 Regulate Hematopoietic Stem and Progenitor Cell Fitness. Stem Cell Reports. 5(4). 633–646. 14 indexed citations

18.

Puissant, Alexandre, Nina Fenouille, Gabriela Alexe, et al.. (2014). SYK Is a Critical Regulator of FLT3 in Acute Myeloid Leukemia. Cancer Cell. 25(2). 226–242. 109 indexed citations

19.

Hasan, Md. Ashraful, et al.. (2011). Maximum likelihood analysis of mammalian p53 indicates the presence of positively selected sites and higher tumorigenic mutations in purifying sites. Gene. 483(1-2). 29–35. 6 indexed citations

20.

Kazi, Julhash U., I. Bernard Weinstein, & Jae‐Won Soh. (2007). Celecoxib-induced growth inhibiton in SW480 colon cancer cells is associated with activation of protein kinase G. Molecular Cancer Therapeutics. 6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact